Semaglutide in Patients with Obesity and Psoriasis: Insights from an 18-Month Real-World Experience.
Summary withdrawn
TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.